These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6407653)

  • 21. Complete biliary obstruction due to erythromycin estolate administration in an infant.
    Krowchuk D; Seashore JH
    Pediatrics; 1979 Dec; 64(6):956-8. PubMed ID: 514726
    [No Abstract]   [Full Text] [Related]  

  • 22. A prospective study on the incidence of liver function abnormalities in children receiving erythromycin estolate, erythromycin ethylsuccinate or penicillin V for treatment of pneumonia.
    Ginsburg CM
    Pediatr Infect Dis; 1986; 5(1):151-3. PubMed ID: 3080735
    [No Abstract]   [Full Text] [Related]  

  • 23. [Jaundice caused by erythromycin estolate].
    Persico L
    Policlinico Prat; 1969 Jan; 76(2):33-41. PubMed ID: 4236690
    [No Abstract]   [Full Text] [Related]  

  • 24. Infantile hypertrophic pyloric stenosis related to ingestion of erythromycine estolate: A report of five cases.
    SanFilippo A
    J Pediatr Surg; 1976 Apr; 11(2):177-80. PubMed ID: 1263054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Erythromycin-induced hepatitis].
    Perrier M; Portier G; de Calan L; Favre JP; Ozoux JP; Rivallain B; Brizon J
    Cah Anesthesiol; 1987; 35(3):237. PubMed ID: 3621021
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of erythromycin ethyl succinate, stearate and estolate treatments of group A streptococcal infections of the upper respiratory tract.
    Janicki RS; Garnham JC; Worland MC; Grundy WE; Thomas JR
    Clin Pediatr (Phila); 1975 Dec; 14(12):1098-107. PubMed ID: 1104241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The treatment of beta hemolytic streptococcal pharyngitis. Comparison of amoxicillin, erythromycin estolate, and penicillin V.
    Breese BB; Disney FA; Green JL; Talpey WB
    Clin Pediatr (Phila); 1977 May; 16(5):460-3. PubMed ID: 403044
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of erythromycin base and estolate in gonococcal urethritis.
    Brown ST; Pedersen HB; Holmes KK
    JAMA; 1977 Sep; 238(13):1371-3. PubMed ID: 408522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erythromycin estolate impairs the mitochondrial and microsomal calcium homeostasis: correlation with hepatotoxicity.
    Richelmi P; Baldi C; Manzo L; Berte F; Martino AP; Mirabelli F; Bellomo G
    Arch Toxicol Suppl; 1984; 7():298-302. PubMed ID: 6595996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A simple thin-layer chromatographic identification procedure for erythromycin base, stearate, estolate and ethylsuccinate.
    Vilim A; LeBelle MJ; Wilson WL; Graham KC
    J Chromatogr; 1977 Mar; 133(1):239-44. PubMed ID: 838805
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacokinetics of erythromycin ethylsuccinate and estolate in infants under 4 months of age.
    Patamasucon P; Kaojarern S; Kusmiesz H; Nelson JD
    Antimicrob Agents Chemother; 1981 May; 19(5):736-9. PubMed ID: 6975059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ilosone update.
    Culp ER
    Am Fam Physician; 1980 Apr; 21(4):23. PubMed ID: 7377065
    [No Abstract]   [Full Text] [Related]  

  • 33. Protective role of tetrahydrocurcumin against erythromycin estolate-induced hepatotoxicity.
    Pari L; Murugan P
    Pharmacol Res; 2004 May; 49(5):481-6. PubMed ID: 14998559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythromycin hepatotoxicity. A rare cause of a false-positive technetium-99m DISIDA study.
    Swayne LC; Kolc J
    Clin Nucl Med; 1986 Jan; 11(1):10-2. PubMed ID: 3943237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic advantages of erythromycin estolate over ethylsuccinate as determined by high-pressure liquid chromatography.
    Croteau D; Bergeron MG; LeBel M
    Antimicrob Agents Chemother; 1988 Apr; 32(4):561-5. PubMed ID: 3259856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case study: Drug interference in clinical chemistry.
    Hansen JL; Swanson LN
    Am J Med Technol; 1981 Mar; 47(3):189-91. PubMed ID: 7223765
    [No Abstract]   [Full Text] [Related]  

  • 37. [Controlled study of the liver-protective effect of cycloxilic acid in a form of iatrogenic liver disease].
    Neuman M; Fluteau G
    Clin Ter; 1978 Nov; 87(3):243-64. PubMed ID: 380876
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative bioavailability evaluation of erythromycin base and its salts and esters. I. Erythromycin estolate capsules versus enteric-coated erythromycin base tablets.
    DiSanto AR; Tserng KY; Chodos DJ; DeSante KA; Albert KS; Wagner JG
    J Clin Pharmacol; 1980 Jul; 20(7):437-43. PubMed ID: 7430412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [On the article of J. Buchanec and V. Kdrajnák: Lesions of the liver during therapy with erythromycin in 3 children].
    Rouzica M; Filipová K
    Cesk Pediatr; 1975 Jan; 30(1-2):71. PubMed ID: 1132045
    [No Abstract]   [Full Text] [Related]  

  • 40. The effects of erythromycin in patients treated with cyclosporine.
    Martell R; Heinrichs D; Stiller CR; Jenner M; Keown PA; Dupre J
    Ann Intern Med; 1986 May; 104(5):660-1. PubMed ID: 3963664
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.